Related references
Note: Only part of the references are listed.Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation
Julia O'Sullivan et al.
NATURE COMMUNICATIONS (2019)
PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers
Carole Beck et al.
CELL DEATH AND DIFFERENTIATION (2019)
Exploring and comparing adverse events between PARP inhibitors
Christopher J. LaFargue et al.
LANCET ONCOLOGY (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation
Gabriella Zarkovic et al.
NUCLEIC ACIDS RESEARCH (2018)
Dna is a New Target of Parp3
E. A. Belousova et al.
SCIENTIFIC REPORTS (2018)
PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines
Bahram Sharif-Askari et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Parp3 promotes long-range end joining in murine cells
Jacob Layer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A New DNA Break Repair Pathway Involving PARP3 and Base Excision Repair Proteins
E. A. Belousova et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2018)
Reversible mono-ADP-ribosylation of DNA breaks
Deeksha Munnur et al.
FEBS JOURNAL (2017)
ADP-ribosylation of DNA moving into focus
Christian Dolle et al.
FEBS JOURNAL (2017)
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Rebecca Gupte et al.
GENES & DEVELOPMENT (2017)
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA
Tovah A. Day et al.
NATURE COMMUNICATIONS (2017)
Redox regulation in tumor cell epithelial-mesenchymal transition: molecular basis and therapeutic strategy
Jingwen Jiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2BGlu2
Gabrielle J. Grundy et al.
NATURE COMMUNICATIONS (2016)
PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis
Olga Karicheva et al.
ONCOTARGET (2016)
Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation
Junghui Koo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
PARP3 interacts with FoxM1 to confer glioblastoma cell radioresistance
Jun-Jie Quan et al.
TUMOR BIOLOGY (2015)
Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
Matthew L. Fisher et al.
ONCOTARGET (2015)
Parp3 Negatively Regulates Immunoglobulin Class Switch Recombination
Isabelle Robert et al.
PLOS GENETICS (2015)
TGF beta 1 Protects Cells from gamma-IR by Enhancing the Activity of the NHEJ Repair Pathway
Mi-Ra Kim et al.
MOLECULAR CANCER RESEARCH (2015)
mTOR Regulate EMT Through RhoA and Rac1 Pathway in Prostate Cancer
XianGuo Chen et al.
MOLECULAR CARCINOGENESIS (2015)
Nox4-Mediated Cell Signaling Regulates Differentiation and Survival of Neural Crest Stem Cells
Ji-Eun Lee et al.
MOLECULES AND CELLS (2014)
PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways
Carole Beck et al.
NUCLEIC ACIDS RESEARCH (2014)
PARP-2 and PARP-3 are selectively activated by 5' phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1
Marie-France aEuro Langelier et al.
NUCLEIC ACIDS RESEARCH (2014)
PARP Inhibitor with Selectivity Toward ADP-Ribosyltransferase ARTD3/PARP3
Anders E. G. Lindgren et al.
ACS CHEMICAL BIOLOGY (2013)
The PARP3-and ATM-dependent phosphorylation of APLF facilitates DNA double-strand break repair
Amanda L. Fenton et al.
NUCLEIC ACIDS RESEARCH (2013)
Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
L. Cao et al.
ONCOGENE (2012)
Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells
Chun-Yu Lin et al.
MOLECULAR CANCER (2011)
PARP-3 and APLF Function Together to Accelerate Nonhomologous End-Joining
Stuart L. Rulten et al.
MOLECULAR CELL (2011)
A Key Role for Poly(ADP-Ribose) Polymerase 3 in Ectodermal Specification and Neural Crest Development
Michele Rouleau et al.
PLOS ONE (2011)
Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression
Christian Boehler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
PARP-3 Is a Mono-ADP-ribosylase That Activates PARP-1 in the Absence of DNA
Olga Loseva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells
Anupam Kumar et al.
PLOS ONE (2010)
Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
Minghai Shao et al.
CANCER RESEARCH (2009)
mTOR signaling at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2009)
BRCA1 dysfunction in sporadic basal-like breast cancer
N. C. Turner et al.
ONCOGENE (2007)
Inhibition of transforming growth factor-β1 signaling attenuates ataxia telanglectasia mutated activity in response to genotoxic stress
Julia Kirshner et al.
CANCER RESEARCH (2006)
Basal-like breast cancer and the BRCA1 phenotype
N. C. Turner et al.
ONCOGENE (2006)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Share Paper
